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. NanoBEADS Viability. Composite bright-field and fluorescence microscopy images of unmodified bacteria and NanoBEADS (left column). The fluorescence microscopy images (right column) show live bacteria (green) and dead bacteria (red). Conjugation of nanoparticles (22±14) to bacteria through biotin-streptavidin affinity bonds does not affect bacteria viability. All scale bars are 20 µm. Figure S1 . Dynamic Light Scattering Analysis. Representative intensity-size distribution plot of TIPS pentacene-loaded PLGA nanoparticles in PBS at a concentration of ~0.02 mg mL -1 . The polydispersity index (PDI)=0.11 suggests a narrow size distribution. Figure S4 . Effect of Antibody Concentration on NanoBEADS Formation. At nanoparticle to bacteria assembly ratio of 50:1, the fraction of bacteria with at least one nanoparticle attached steadily rose with increasing concentration of antibody till the maximum concentration of 10 µg mL -1 . For HCT-116 tumor spheroids, N=10 for PEGylated bacteria, N=9 for NanoBEADS, and N=7 for nanoparticles. For U87MG tumor spheroids, N=7 for PEGylated bacteria, N=7 for NanoBEADS, and N=7 for nanoparticles. For 4T1 tumor spheroids, N=7 for PEGylated bacteria, N=4 for NanoBEADS, and N=3 for nanoparticles.
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Figure S9. Collagen Content in Tumor Spheroids. Representative confocal microscopy images and quantification of collagen type I immunofluorescence staining in HCT-116 human colon carcinoma, U87MG human glioblastoma, or 4T1 murine mammary carcinoma tumor slices. Green, collagen I staining; blue, DAPI. All scale bars are 50 µm. Typhimurium VNP20009, and NanoBEADS through 4T1 mammary tumors in BALB/c mice 48 h after intratumoral injection. The point of injection is considered as the radial coordinate origin in PI calculations. Each NanoBEADS agent carries an average of 22 nanoparticles, thus, it significantly enhances the intratumoral retention of nanoparticles.
Figure S12. Intratumoral Transport of Therapeutic Agents in a Murine Breast Cancer Model.
Confocal microscopy images showing the penetration of PLGA nanoparticles, PEGylated S. Typhimurium VNP20009, and NanoBEADS through 4T1 mammary tumors in BALB/c mice 48 h after intratumoral injection. The point of injection was considered to be at the end of the needle track, marked with asterisks on the images (top row). Zoomed-in micrographs with white arrows pointing to representative therapeutic agents (bottom row).
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II. Image Processing for Quantitation of the Spatial Distribution of Therapeutic Agents in Tumor Slices
We developed a custom image processing routine to quantitate and produce a 3D map of the therapeutic agents in tumor slices that were imaged using a laser scanning confocal microscope. Our algorithm is comprised of three components: (i) Calibration of the size and intensity of the object of interest: sample images containing sparsely distributed singular therapeutic agents were processed to define average object size or the number of pixels that represent a therapeutic agent. Next, an analytical function was fit to the distribution of fluorescence intensity along the z-axis for a series of representative z-stacked images, and fluorescent signal dissipation with respect to distance in the z-dimension was determined. Together, this data provided the object size information needed to accurately quantify the number of objects; (ii) Conversion of the grayscale fluorescent intensity image into a binary image: User-defined thresholding parameters including global and local gray-level intensity values were applied to convert grayscale input images into binary images; (iii) Construction of the 3D distribution map: using binary images produced in (ii) and the calibration data from (i), a compensation algorithm was utilized to enable the enumeration of fluorescent therapeutic agents in 40 µm-thick tumor slices.
II. A. Error Analysis
In order to determine the accuracy of our image processing routine, we compared the number of fluorescent objects detected by the image processing routine with the number of objects detected by manual counting. The error was calculated according to:
where N manual is the number of objects determined by manual counting and N automated is the number of objects reported by the image processing routine. In the case of nanoparticles, the manual counting was carried out using scanning electron microscopy (SEM) images, whereas, for the larger bacteria and NanoBEADS, the manual counting was done from the confocal microscopy images. It should be noted that, given the co-localization of the nanoparticles and bacteria in the case of NanoBEADS (Figure S6) , only the signal from bacteria (visualized at 543 nm excitation wavelength with a 553-624 band-pass filter) was Figure S14 . Image Processing Error Analysis. The error in quantitation of the spatial distribution of therapeutic agents was determined by comparing the number of fluorescent objects reported by our image processing routine with the number of fluorescent agents determined through manual counting. The mean error was found to be 7.8 ± 1.9 % in the case of bacteria and NanoBEADS and 13.1 ± 1.9 % in the case of nanoparticles.
used for image processing to avoid any error due to variation in the number of PLGA nanoparticles (visualized at 633 nm excitation wavelength with a 635-750 band-pass filter). The bacterial nanoparticle load information was separately determined through analysis of SEM images (Figure 1) . As shown in Figure S14 , we found that the mean error in the bacteria and NanoBEADS case was 7.8 ± 1.9 % (n = 9). The error largely stemmed from the variability in bacteria orientation which leads to variation in their projected area. In the case of nanoparticles, the mean error was 13.1 ± 1.9 % (n = 22). The larger error was due to the smaller size of the nanoparticles combined with the variability in the 3D clustering of the nanoparticles.
